USANA HEALTH SCIENCES INC (USNA) Fundamental Analysis & Valuation
NYSE:USNA • US90328M1071
Current stock price
16.9 USD
-0.32 (-1.86%)
At close:
17 USD
+0.1 (+0.59%)
After Hours:
This USNA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. USNA Profitability Analysis
1.1 Basic Checks
- In the past year USNA was profitable.
- USNA had a positive operating cash flow in the past year.
- Each year in the past 5 years USNA has been profitable.
- USNA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- USNA has a Return On Assets (2.34%) which is comparable to the rest of the industry.
- The Return On Equity of USNA (3.22%) is better than 67.57% of its industry peers.
- With a Return On Invested Capital value of 5.43%, USNA perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for USNA is in line with the industry average of 11.42%.
- The last Return On Invested Capital (5.43%) for USNA is well below the 3 year average (9.82%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROIC | 5.43% |
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
1.3 Margins
- The Profit Margin of USNA (1.86%) is comparable to the rest of the industry.
- In the last couple of years the Profit Margin of USNA has declined.
- Looking at the Operating Margin, with a value of 4.58%, USNA is in line with its industry, outperforming 56.76% of the companies in the same industry.
- USNA's Operating Margin has declined in the last couple of years.
- USNA has a Gross Margin of 79.18%. This is amongst the best in the industry. USNA outperforms 94.59% of its industry peers.
- In the last couple of years the Gross Margin of USNA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% |
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
2. USNA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), USNA is creating some value.
- The number of shares outstanding for USNA has been reduced compared to 1 year ago.
- Compared to 5 years ago, USNA has less shares outstanding
- The debt/assets ratio for USNA has been reduced compared to a year ago.
2.2 Solvency
- USNA has an Altman-Z score of 3.52. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
- USNA has a Altman-Z score of 3.52. This is in the better half of the industry: USNA outperforms 75.68% of its industry peers.
- USNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.52 |
ROIC/WACC0.63
WACC8.64%
2.3 Liquidity
- A Current Ratio of 2.23 indicates that USNA has no problem at all paying its short term obligations.
- USNA has a Current ratio (2.23) which is in line with its industry peers.
- USNA has a Quick Ratio of 1.46. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
- USNA's Quick ratio of 1.46 is fine compared to the rest of the industry. USNA outperforms 62.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 |
3. USNA Growth Analysis
3.1 Past
- The earnings per share for USNA have decreased strongly by -26.15% in the last year.
- The earnings per share for USNA have been decreasing by -20.00% on average. This is quite bad
- The Revenue has grown by 8.28% in the past year. This is quite good.
- USNA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
3.2 Future
- The Earnings Per Share is expected to grow by 21.31% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 4.02% on average over the next years.
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. USNA Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.80, the valuation of USNA can be described as very reasonable.
- 86.49% of the companies in the same industry are more expensive than USNA, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 25.60, USNA is valued rather cheaply.
- With a Price/Forward Earnings ratio of 8.28, the valuation of USNA can be described as very reasonable.
- USNA's Price/Forward Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 81.08% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 22.84. USNA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.8 | ||
| Fwd PE | 8.28 |
4.2 Price Multiples
- 97.30% of the companies in the same industry are more expensive than USNA, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.56 |
4.3 Compensation for Growth
- USNA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- USNA's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.41
PEG (5Y)N/A
EPS Next 2Y21.31%
EPS Next 3YN/A
5. USNA Dividend Analysis
5.1 Amount
- No dividends for USNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
USNA Fundamentals: All Metrics, Ratios and Statistics
16.9
-0.32 (-1.86%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-17 2026-02-17/amc
Earnings (Next)04-20 2026-04-20/amc
Inst Owners58.34%
Inst Owner Change0.34%
Ins Owners0.65%
Ins Owner Change0.54%
Market Cap308.93M
Revenue(TTM)925.26M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (135.38%)
Short Float %4.37%
Short Ratio3.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)2.56%
EPS NY rev (3m)5.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.34%
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)4.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.8 | ||
| Fwd PE | 8.28 | ||
| P/S | 0.34 | ||
| P/FCF | N/A | ||
| P/OCF | 9.8 | ||
| P/B | 0.59 | ||
| P/tB | 1.26 | ||
| EV/EBITDA | 2.56 |
EPS(TTM)1.92
EY11.36%
EPS(NY)2.04
Fwd EY12.07%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY10.2%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)1.41
PEG (5Y)N/A
Graham Number35.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROCE | 6.88% | ||
| ROIC | 5.43% | ||
| ROICexc | 7.14% | ||
| ROICexgc | 18.34% | ||
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% | ||
| FCFM | N/A |
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
ROICexc(3y)20.39%
ROICexc(5y)37.76%
ROICexgc(3y)38.56%
ROICexgc(5y)58.83%
ROCE(3y)12.43%
ROCE(5y)20.38%
ROICexgc growth 3Y-33.6%
ROICexgc growth 5Y-29.38%
ROICexc growth 3Y-44.57%
ROICexc growth 5Y-36.69%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
F-Score7
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 973.94% | ||
| Cap/Sales | 23.69% | ||
| Interest Coverage | 62.89 | ||
| Cash Conversion | 49.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 | ||
| Altman-Z | 3.52 |
F-Score7
WACC8.64%
ROIC/WACC0.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-22.1%
EBIT growth 5Y-22.03%
EBIT Next Year32.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-381.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.2%
OCF growth 3YN/A
OCF growth 5YN/A
USANA HEALTH SCIENCES INC / USNA Fundamental Analysis FAQ
What is the fundamental rating for USNA stock?
ChartMill assigns a fundamental rating of 5 / 10 to USNA.
Can you provide the valuation status for USANA HEALTH SCIENCES INC?
ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.
What is the profitability of USNA stock?
USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for USNA stock?
The Price/Earnings (PE) ratio for USANA HEALTH SCIENCES INC (USNA) is 8.8 and the Price/Book (PB) ratio is 0.59.
What is the expected EPS growth for USANA HEALTH SCIENCES INC (USNA) stock?
The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 6.25% in the next year.